人体器官芯片在FDA评估和制药管道中的挑战和机会
1Wyss Institute for Biologically Inspired Engineering at Harvard University, 201 Brookline Ave., Suite 401, Boston, MA 02215, USA; Vascular Biology Program and Department of Surgery, Boston Children's Hospital and Harvard Medical School, Boston, MA 02115, USA; Harvard John A. Paulson School of Engineering and Applied Sciences, Cambridge, MA 02134, USA.
Cell stem cell
|January 21, 2026
概括
人体器官芯片技术为药物开发提供了对动物试验的有希望的替代方案. 克服当前的挑战将使更广泛的采用,减少动物使用和提高药物成功率.
科学领域:
- 生物技术是生物技术.
- 药物开发 药物开发
- 毒理学 毒理学 毒理学
背景情况:
- 美国食品和药物管理局 (FDA) 正在逐步取消对药物评估的动物试验.
- 新方法方法 (NAMs),如人体器官芯片 (Organ Chip) 技术,正在推动药物评估.
- 器官芯片技术目前正在制药研究中进行探索,但尚未集成到药物开发管道中.
研究的目的:
- 审查与将器官芯片技术整合到药物开发中的挑战和机会.
- 讨论器官芯片所需的未来工作,以减少动物使用,降低药物成本,提高临床成功.
主要方法:
- 审查目前的器官芯片技术的研究和开发.
- 对监管趋势和制药行业采用障碍的分析.
- 讨论器官芯片应用的潜在好处和未来研究方向.
主要成果:
- 器官芯片技术为传统的动物试验提供了可行的替代品,用于药物的有效性和毒性.
- 在器官芯片数据的扩展,标准化和监管接受方面仍然存在重大挑战.
- 成功整合可能会导致更具预测性的临床前模型,并减少对动物研究的依赖.
结论:
- 器官芯片技术通过减少动物使用和提高预测准确性来改变药物开发的重大前景.
- 解决技术和监管障碍对于在制药管道中广泛采用器官芯片至关重要.
- 需要进一步的研究和合作,才能充分发挥器官芯片在实现监管目标和改善患者治疗结果方面的潜力.
相关概念视频
FDA Approved Drugs: Changes to Approved Drugs
247
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
247
Structural Organization of the Human Body: An Overview
26.8K
It is convenient to consider the body's structures in terms of fundamental levels of organization that increase in complexity: subatomic particles, atoms, molecules, organelles, cells, tissues, organs, organ systems, and organisms.
To study the chemical level of organization, scientists consider the simplest building blocks of matter: subatomic particles, atoms, and molecules. All matter in the universe is composed of one or more unique pure substances called elements, familiar examples of...
To study the chemical level of organization, scientists consider the simplest building blocks of matter: subatomic particles, atoms, and molecules. All matter in the universe is composed of one or more unique pure substances called elements, familiar examples of...
26.8K
Organization of Genes
73.2K
Overview
73.2K
Levels of Organization
139.0K
Biological organization is the classification of biological structures, ranging from atoms at the bottom of the hierarchy to the Earth's biosphere. Each level of the hierarchy represents an increase in complexity that builds upon the previous level.
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
139.0K
Accessory Organs
74.0K
Accessory organs are those that participate in the digestion of food but do not come into direct contact with it like the mouth, stomach, or intestine do. Accessory organs secrete enzymes into the digestive tract to facilitate the breakdown of food.
74.0K
Organic Compounds
56.8K
All living things are formed mostly of carbon compounds called organic compounds. The category of organic compounds includes both natural and synthetic compounds that contain carbon. Although a single, precise definition has yet to be identified by the chemistry community, most agree that a defining trait of organic molecules is the presence of carbon as the principal element, bonded to hydrogen and other carbon atoms. However, some carbon-containing compounds such as carbonates, cyanides, and...
56.8K


